Wolverine Trading, LLC Biogen Inc. Transaction History

Wolverine Trading, LLC

$93.9 Billion
Q3 2024

A detailed history of Wolverine Trading, LLC transactions in Biogen Inc. stock. As of the latest transaction made, Wolverine Trading, LLC holds 8,121 shares of BIIB stock, worth $1.19 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

8,121

Previous 10,435 22.18%

Holding current value

$1.19 Million

Previous $2.42 Million 34.93%

% of portfolio

0.0%

Previous 0.0%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$189.07 - $236.8 $437,507 - $547,955	-2,314 Reduced 22.18%	8,121 $1.57 Million
Q2 2024 Aug 14, 2024	BUY	$190.52 - $236.72 $491,922 - $611,211	2,582 Added 32.88%	10,435 $2.42 Million
Q1 2024 May 15, 2024	BUY	$212.02 - $267.71 $255,696 - $322,858	1,206 Added 18.14%	7,853 $1.69 Million
Q4 2023 Feb 14, 2024	SELL	$222.59 - $267.94 $1.78 Million - $2.15 Million	-8,017 Reduced 54.67%	6,647 $1.72 Million
Q3 2023 Nov 15, 2023	BUY	$253.3 - $285.89 $2.27 Million - $2.56 Million	8,957 Added 156.95%	14,664 $3.77 Million
Q2 2023 Aug 23, 2023	BUY	$275.25 - $318.06 $1.26 Million - $1.46 Million	4,578 Added 405.49%	5,707 $1.63 Million
Q1 2023 May 15, 2023	SELL	$256.56 - $292.34 $2.71 Million - $3.09 Million	-10,579 Reduced 90.36%	1,129 $311,000
Q4 2022 Feb 14, 2023	SELL	$252.44 - $306.72 $795,690 - $966,781	-3,152 Reduced 21.21%	11,708 $3.24 Million
Q3 2022 Nov 14, 2022	SELL	$194.69 - $268.46 $849,821 - $1.17 Million	-4,365 Reduced 22.7%	14,860 $3.93 Million
Q2 2022 Aug 15, 2022	SELL	$187.54 - $223.02 $216,046 - $256,919	-1,152 Reduced 5.65%	19,225 $3.95 Million
Q1 2022 May 16, 2022	SELL	$193.77 - $244.14 $1.06 Million - $1.33 Million	-5,460 Reduced 21.13%	20,377 $4.3 Million
Q4 2021 Feb 14, 2022	BUY	$223.92 - $287.77 $2.43 Million - $3.12 Million	10,835 Added 72.22%	25,837 $6.2 Million
Q3 2021 Nov 12, 2021	SELL	$282.99 - $369.05 $1.49 Million - $1.94 Million	-5,267 Reduced 25.99%	15,002 $4.28 Million
Q2 2021 Aug 06, 2021	SELL	$259.0 - $414.71 $1.34 Million - $2.14 Million	-5,162 Reduced 20.3%	20,269 $7.01 Million
Q1 2021 May 14, 2021	SELL	$242.95 - $284.63 $3.67 Million - $4.3 Million	-15,103 Reduced 37.26%	25,431 $7.02 Million
Q4 2020 Feb 12, 2021	BUY	$236.26 - $355.63 $4.61 Million - $6.95 Million	19,529 Added 92.97%	40,534 $9.87 Million
Q3 2020 Nov 13, 2020	BUY	$264.77 - $305.71 $639,419 - $738,289	2,415 Added 12.99%	21,005 $5.93 Million
Q2 2020 Aug 13, 2020	SELL	$258.66 - $342.55 $218,567 - $289,454	-845 Reduced 4.35%	18,590 $4.84 Million
Q1 2020 May 11, 2020	SELL	$268.85 - $341.04 $2.9 Million - $3.68 Million	-10,781 Reduced 35.68%	19,435 $6.14 Million
Q4 2019 Feb 12, 2020	SELL	$220.06 - $304.07 $4.55 Million - $6.28 Million	-20,655 Reduced 40.6%	30,216 $8.94 Million
Q3 2019 Nov 14, 2019	BUY	$217.44 - $243.88 $4.92 Million - $5.52 Million	22,618 Added 80.06%	50,871 $11.7 Million
Q2 2019 Aug 20, 2019	SELL	$219.29 - $241.72 $3.13 Million - $3.45 Million	-14,262 Reduced 33.55%	28,253 $6.61 Million
Q1 2019 May 15, 2019	BUY	$216.71 - $338.96 $8 Million - $12.5 Million	36,921 Added 660.01%	42,515 $10.1 Million
Q4 2018 Feb 14, 2019	SELL	$278.5 - $352.75 $1.97 Million - $2.49 Million	-7,066 Reduced 55.81%	5,594 $1.64 Million
Q1 2018 May 15, 2018	SELL	$260.13 - $367.91 $3.52 Million - $4.98 Million	-13,545 Reduced 51.69%	12,660 $3.47 Million
Q4 2017 Feb 14, 2018	BUY	$307.64 - $344.58 $7.23 Million - $8.1 Million	23,511 Added 872.72%	26,205 $8.35 Million
Q3 2017 Nov 15, 2017	BUY	$281.15 - $329.69 $757,418 - $888,184	2,694	2,694 $844,000

Others Institutions Holding BIIB

# of Institutions

1,037

Shares Held

126M

Call Options Held

1.13M

Put Options Held

1.43M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $21.1B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Trading, LLC with notifications on news.

Account

Wolverine Trading, LLC Biogen Inc. Transaction History